PMC17 SHOULD INDIRECT COSTS OF ILLNESS BE INCLUDED IN PHARMACOECONOMIC ANALYSIS: SURVEY AMONG POLISH DECISION MAKERS AND EXPERTS

Authors :: Maciej Niewada
W Wrona
Dominik Golicki
Tomasz Hermanowski
Marcin Czech
T Macioch
Michał Jakubczyk
Source :: Value in Health. 12:A389-A390
Publication Year :: 2009
Publisher :: Elsevier BV, 2009.

Subjects :: Indirect costs
Public economics
Health Policy
Public Health, Environmental and Occupational Health
Business

Full Text Access

Tools